Alzheimer's Disease Research Today is a free monthly online journal that collates and summarizes the latest research about Alzheimer's Disease, including details on diagnosis, memory loss, heredity, treatment, medication.

Volume 5 (2008), Issue 8 (August)

1. IFN-gamma enhances neurogenesis in wild-type mice and in a mouse model of Alzheimer's disease.
   FASEB J, 22(8): 2843-52. [Abstract] [Full-text]
2. Apolipoprotein E epsilon4 allele genotype and the effect of depressive symptoms on the risk of dementia in men: the Honolulu-Asia Aging Study.
   Arch Gen Psychiatry, 65(8): 906-12. [Abstract] [Full-text]
3. Rapid improvement in verbal fluency and aphasia following perispinal etanercept in Alzheimer's disease.
   BMC Neurol, 8: 27. [Abstract] [Full-text]
4. Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory.
   Nat Med, 14(8): 837-42. [Abstract] [Full-text]
5. Inhibition of acetylcholinesterase, beta-amyloid aggregation, and NMDA receptors in Alzheimer's disease: a promising direction for the multi-target-directed ligands gold rush.
   J Med Chem, 51(15): 4381-4. [Abstract] [Full-text]
6. Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer's disease mice.
   J Neurosci, 28(33): 8354-60. [Abstract] [Full-text]
7. Safety, efficacy, and biomarker findings of PBT2 in targeting Abeta as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial.
   Lancet Neurol, 7(9): 779-86. [Abstract] [Full-text]
8. Amyloid-beta immunisation for Alzheimer's disease.
   Lancet Neurol, 7(9): 805-11. [Abstract] [Full-text]
9. Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors.
   Lancet Neurol, 7(9): 812-26. [Abstract] [Full-text]
10. Age-related differences in NFkappaB translocation and Bcl-2/Bax ratio caused by TNFalpha and Abeta42 promote survival in middle-age neurons and death in old neurons.
    Exp Neurol, 213(1): 93-100. [Abstract] [Full-text]
11. Toll-like receptor-4 mediates neuronal apoptosis induced by amyloid beta-peptide and the membrane lipid peroxidation product 4-hydroxynonenal.
    Exp Neurol, 213(1): 114-21. [Abstract] [Full-text]
12. Nobiletin, a citrus flavonoid, improves memory impairment and Abeta pathology in a transgenic mouse model of Alzheimer's disease.
    J Pharmacol Exp Ther, 326(3): 739-44. [Abstract] [Full-text]
13. Transgenic tomatoes expressing human beta-amyloid for use as a vaccine against Alzheimer's disease.
    Biotechnol Lett, 30(10): 1839-45. [Abstract] [Full-text]
14. Developing new treatments for Alzheimer's disease: the who, what, when, and how of biomarker-guided therapies.
    Int Psychogeriatr, 20(5): 871-89. [Abstract] [Full-text]
15. Association between apathy/depression and executive function in patients with Alzheimer's disease.
    Int Psychogeriatr, 20(5): 964-75. [Abstract] [Full-text]
16. Illiteracy and the incidence of Alzheimer's disease in the Yonchon County survey, Korea.
    Int Psychogeriatr, 20(5): 976-85. [Abstract] [Full-text]
17. Decreased initiation of usual activities in people with mild-to-moderate Alzheimer's disease: a descriptive analysis from the VISTA clinical trial.
    Int Psychogeriatr, 20(5): 952-63. [Abstract] [Full-text]
18. Genetic variability in progranulin contributes to risk for clinically diagnosed Alzheimer disease.
    Neurology, 71(9): 656-64. [Abstract] [Full-text]
19. Association study of the NEDD9 gene with the risk of developing Alzheimer's and Parkinson's disease.
    Hum Mol Genet, 17(18): 2863-7. [Abstract] [Full-text]
20. Neuronal apoptosis and autophagy cross talk in aging PS/APP mice, a model of Alzheimer's disease.
    Am J Pathol, 173(3): 665-81. [Abstract] [Full-text]
21. Amyloid plaque and neurofibrillary tangle pathology in a regulatable mouse model of Alzheimer's disease.
    Am J Pathol, 173(3): 762-72. [Abstract] [Full-text]

© 2004-2008 Alzheimer's Disease Research Today. All Rights Reserved.